Ms. kirti Upadhyay | Cytogenetic | Best Researcher Award
Ms. kirti Upadhyay | Cytogenetic | King George’s Medical University | India
Ms. Kirti Upadhyay is a dedicated Ph.D. scholar at the Cytogenetics Lab, Centre for Advanced Research, King George’s Medical University, Lucknow, specializing in cytogenetics, molecular biology, biochemistry, and metabolomics, with a strong focus on chromosomal studies, DNA/RNA analysis, and hematological genetics. She has acquired a robust academic foundation with a B.Sc. in Life Sciences from Deen Dayal Upadhyay Gorakhpur University, an M.Sc. in Zoology from Maharishi University of Information Technology, and is currently pursuing her doctoral research in cytogenetics. Throughout her academic journey, Ms. Kirti Upadhyay has demonstrated consistent involvement in research projects including national and international workshops, conferences, and collaborative programs, emphasizing precision medicine, cancer biology, forensic genetics, and gene cloning. Her professional experience encompasses extensive laboratory skills such as karyotyping, FISH, DNA/RNA isolation, PCR, RFLP, microarray analysis, ELISA, electrophoresis, chromatography, and metabolomics analysis via GC-MS, enabling her to conduct complex biomedical experiments independently and with precision. Ms. Kirti Upadhyay has actively participated in organizing conferences, symposia, and workshops, including the Annual Thalassemia Update, International Conference on Advances in Cytogenetics, and Cochrane India Network Conference, reflecting her leadership and community engagement in scientific research.
Professional Profile: ORCID
Selected Publications:
-
High-Resolution Genetic Profiling of Hb J-Meerut and Other Hemoglobin Variants in the Tharu Population via HPLC and DNA Sequencing – 2025 – Citations: 12
-
Prevalence and Detection of Novel Thalassemia Variant Hemoglobin J in Extensive Tharu Population – 2025 – Citations: 9
-
From Chromosomes to Clinics: Cytogenetic Insights and Drug Treatments in Down Syndrome – 2025 – Citations: 7
-
Current and Future Therapeutic Approaches of CFTR and Airway Dysbiosis in an Era of Personalized Medicine – 2025 – Citations: 5